These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8180816)

  • 1. Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease.
    Gertz HJ; Siegers A; Kuchinke J
    Brain Res; 1994 Feb; 637(1-2):339-41. PubMed ID: 8180816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphochemical changes in the substantia nigra cellular structures in Parkinson's disease].
    Salkov VN; Khudoerkov RM; Voronkov DN; Sobolev VB; Kutukova KA
    Arkh Patol; 2017; 79(5):3-9. PubMed ID: 29027522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between Lewy bodies and pale bodies in Parkinson's disease.
    Dale GE; Probst A; Luthert P; Martin J; Anderton BH; Leigh PN
    Acta Neuropathol; 1992; 83(5):525-9. PubMed ID: 1320323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
    Tompkins MM; Basgall EJ; Zamrini E; Hill WD
    Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of cell size and nucleolar size in tangle-bearing neurons of the hippocampus in Alzheimer's disease.
    Gertz HJ; Schoknecht G; Krüger H; Cervos-Navarro J
    Brain Res; 1989 May; 487(2):373-5. PubMed ID: 2731050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
    Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centenary of Tretiakoff's thesis on the morphology of Parkinson's disease, evolved on the grounds of encephalitis lethargica pathology.
    Holdorff B
    J Hist Neurosci; 2019; 28(4):387-398. PubMed ID: 31226240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain.
    Issidorides MR; Mytilineou C; Whetsell WO; Yahr MD
    Arch Neurol; 1978 Oct; 35(10):633-7. PubMed ID: 697603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
    Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
    Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ageing and Parkinson's disease: substantia nigra regional selectivity.
    Fearnley JM; Lees AJ
    Brain; 1991 Oct; 114 ( Pt 5)():2283-301. PubMed ID: 1933245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lewy bodies in Parkinson's disease: histological, immunohistochemical, and interferometric examinations].
    Voronkov DN; Salkov VN; Anufriev PL; Khudoerkov RM
    Arkh Patol; 2018; 80(4):9-13. PubMed ID: 30059066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.
    Shashidharan P; Good PF; Hsu A; Perl DP; Brin MF; Olanow CW
    Brain Res; 2000 Sep; 877(2):379-81. PubMed ID: 10986355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism.
    Hayashida K; Oyanagi S; Mizutani Y; Yokochi M
    Acta Neuropathol; 1993; 85(4):445-8. PubMed ID: 8480516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuromythology of Parkinson's Disease.
    Calne DB; Mizuno Y
    Parkinsonism Relat Disord; 2004 Jul; 10(5):319-22. PubMed ID: 15196512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.